Yuta Hiraike
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Yuta Hiraike has a total of 65 co-authors. Here are the top co-authors by number of shared publications:
- Toshimasa Yamauchi
Department of Diabetes and Metabolic Diseases, Graduate School of Medicine The University of Tokyo Tokyo Japan
5 shared publications - Chia-Lin Lee
Department of Post-Baccalaureate Medicine, College of Medicine, National Chung Hsing University, Taichung, Taiwan
4 shared publications Kaede Saito
Division for Health Service Promotion, The University of Tokyo , 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-0033
4 shared publicationsMisato Oguchi
Department of Diabetes and Metabolic Diseases, Graduate School of Medicine, The University of Tokyo, Tokyo 113-8655, Japan
3 shared publicationsShintaro Yanagimoto
Division for Health Service Promotion, The University of Tokyo, Tokyo, Japan
3 shared publications- Tomohide Yamada
Department of Diabetes and Metabolic Diseases, Graduate School of Medicine, University of Tokyo, Tokyo, Japan
3 shared publications
Latest Publications
- Open Access
- 16 February 2026
- Published by Springer Nature in Nature Communications
- Vol. 17  (1) , 1396
Machine learning-predicted insulin resistance is a risk factor for 12 types of cancer
Insulin resistance is suggested to be a risk factor for cancer; however, large-scale epidemiological evidence linking insulin resistance to cancer remains limited. Here we apply a machine learning-based prediction model of insulin resistance with nine clinical parameters, termed artificial intelligence-derived insulin resistance (AI-IR), to the UK Biobank and demonstrated that AI-IR exhibits the highest predictive performance for diabetes incidence compared to body mass index (BMI), metabolic syndrome (MetS), triglyceride to high-density lipoprotein cholesterol (TG/HDL) ratio, and triglyceride-glucose (TyG) index. Moreover, AI-IR is significantly associated with an increased risk of six cancers (uterine, kidney, esophagus, pancreas, colon, and breast) and showed nominal associations with six additional cancers (renal pelvis, small intestine, stomach, liver and gallbladder, leukemia, and bronchial and lung). When we define composite cancers by merging cancer types whose risks increase with AI-IR, age- and sex-adjusted hazard ratio is 1.25 (95% confidence interval, 1.20-1.31; P < 1 ×10-11). AI-IR is a better predictor of the composite cancers compared to BMI and TyG index, while its capability is comparable to that of MetS and TG/HDL ratio. We conclude that AI-IR is a robust metric for predicting both diabetes and the composite cancer incidence and could be utilized for identification of high-risk individuals and focused screening.
- 16 February 2026
- Published by Springer Nature in Nature Communications
- Vol. 17  (1) , 1396
Open AccessMachine learning-predicted insulin resistance is a risk factor for 12 types of cancer
Insulin resistance is suggested to be a risk factor for cancer; however, large-scale epidemiological evidence linking insulin resistance to cancer remains limited. Here we apply a machine learning-based prediction model of insulin resistance with nine clinical parameters, termed artificial intelligence-derived insulin resistance (AI-IR), to the UK Biobank and demonstrated that AI-IR exhibits the highest predictive performance for diabetes incidence compared to body mass index (BMI), metabolic syndrome (MetS), triglyceride to high-density lipoprotein cholesterol (TG/HDL) ratio, and triglyceride-glucose (TyG) index. Moreover, AI-IR is significantly associated with an increased risk of six cancers (uterine, kidney, esophagus, pancreas, colon, and breast) and showed nominal associations with six additional cancers (renal pelvis, small intestine, stomach, liver and gallbladder, leukemia, and bronchial and lung). When we define composite cancers by merging cancer types whose risks increase with AI-IR, age- and sex-adjusted hazard ratio is 1.25 (95% confidence interval, 1.20-1.31; P < 1 ×10-11). AI-IR is a better predictor of the composite cancers compared to BMI and TyG index, while its capability is comparable to that of MetS and TG/HDL ratio. We conclude that AI-IR is a robust metric for predicting both diabetes and the composite cancer incidence and could be utilized for identification of high-risk individuals and focused screening.
- 30 December 2025
- Published by Oxford University Press (OUP) in The Journal of Biochemistry
- Vol. 179  (4) , 231-239
Circadian regulation of metabolic homeostasis in physiology and disease
A growing body of evidence indicates that circadian dysregulation—caused by lifestyle factors, such as short sleep, irregular sleep patterns and shift work—constitutes an independent risk factor for insulin resistance, obesity and diabetes. Mammalian circadian rhythms are orchestrated by a conserved transcription–translation feedback loop driven by core transcription factors, which also regulate metabolism-related genes in a tissue-specific manner. Moreover, feeding behaviour and physical activity influence the circadian clock, highlighting a reciprocal relationship between the clock and metabolism. In this review, we discuss circadian regulation of key metabolic organs—including pancreatic β cells, skeletal muscle, liver and adipose tissue—with a focus on molecular metabolisms, and we also highlight relevant human studies to explore the therapeutic potential of targeting the circadian clock. Further investigation into the interplay between the circadian clock and metabolism holds promise for uncovering novel mechanisms and identifying innovative strategies to restore or enhance metabolic homeostasis.
- 30 December 2025
- Published by Oxford University Press (OUP) in The Journal of Biochemistry
- Vol. 179  (4) , 231-239
Circadian regulation of metabolic homeostasis in physiology and disease
A growing body of evidence indicates that circadian dysregulation—caused by lifestyle factors, such as short sleep, irregular sleep patterns and shift work—constitutes an independent risk factor for insulin resistance, obesity and diabetes. Mammalian circadian rhythms are orchestrated by a conserved transcription–translation feedback loop driven by core transcription factors, which also regulate metabolism-related genes in a tissue-specific manner. Moreover, feeding behaviour and physical activity influence the circadian clock, highlighting a reciprocal relationship between the clock and metabolism. In this review, we discuss circadian regulation of key metabolic organs—including pancreatic β cells, skeletal muscle, liver and adipose tissue—with a focus on molecular metabolisms, and we also highlight relevant human studies to explore the therapeutic potential of targeting the circadian clock. Further investigation into the interplay between the circadian clock and metabolism holds promise for uncovering novel mechanisms and identifying innovative strategies to restore or enhance metabolic homeostasis.
- Open Access
- 23 June 2025
- Published by Oxford University Press (OUP) in The Journal of Biochemistry
- Vol. 178  (3) , 147-159
Transcriptional control of brown adipocyte differentiation and function by NFIA: recent perspectives on deciphering metabolic diseases
Brown adipocytes dissipate chemical energy as heat and confer protection against type 2 diabetes and obesity. Nuclear factor I-A (NFIA) is a transcription factor that orchestrates the brown fat gene programme by activating cell type-specific enhancers and facilitating the genomic binding of PPARγ, the master regulator of adipogenesis, to these enhancers. NFIA promotes mitochondrial oxidative phosphorylation and thermogenesis, while reciprocally suppressing adipose tissue inflammation, thereby contributing to the maintenance of glucose and body weight homeostasis in mice. Here the author provides an overview of the identification of NFIA as a pivotal regulator of brown adipocyte biology, elucidates its underlying mechanisms of action, examines its implications for systemic metabolism and outlines future perspectives for research in this field.
- 23 June 2025
- Published by Oxford University Press (OUP) in The Journal of Biochemistry
- Vol. 178  (3) , 147-159
Open AccessTranscriptional control of brown adipocyte differentiation and function by NFIA: recent perspectives on deciphering metabolic diseases
Brown adipocytes dissipate chemical energy as heat and confer protection against type 2 diabetes and obesity. Nuclear factor I-A (NFIA) is a transcription factor that orchestrates the brown fat gene programme by activating cell type-specific enhancers and facilitating the genomic binding of PPARγ, the master regulator of adipogenesis, to these enhancers. NFIA promotes mitochondrial oxidative phosphorylation and thermogenesis, while reciprocally suppressing adipose tissue inflammation, thereby contributing to the maintenance of glucose and body weight homeostasis in mice. Here the author provides an overview of the identification of NFIA as a pivotal regulator of brown adipocyte biology, elucidates its underlying mechanisms of action, examines its implications for systemic metabolism and outlines future perspectives for research in this field.
- 20 July 2024
- Published by Oxford University Press (OUP) in European Journal of Preventive Cardiology
- Vol. 32  (7) , 618
Exploring the effect of physical activity on cardiovascular outcomes in individuals with diabetes: reply
Chia-Lin Lee, Wei-Ju Liu, Yuta Hiraike; Reply to Tsai et al.: Exploring the effect of physical activity on cardiovascular outcomes in individuals with diab
- 20 July 2024
- Published by Oxford University Press (OUP) in European Journal of Preventive Cardiology
- Vol. 32  (7) , 618
Exploring the effect of physical activity on cardiovascular outcomes in individuals with diabetes: reply
Chia-Lin Lee, Wei-Ju Liu, Yuta Hiraike; Reply to Tsai et al.: Exploring the effect of physical activity on cardiovascular outcomes in individuals with diab
- Open Access
- 22 February 2024
- Published by Oxford University Press (OUP) in European Journal of Preventive Cardiology
- Vol. 31  (10) , 1277-1285
Interaction between type 2 diabetes polygenic risk and physical activity on cardiovascular outcomes
Aims: The beneficial effects of exercise on reducing the risk of cardiovascular disease are established. However, the potential interaction between genetic risk for type 2 diabetes and physical activity on cardiovascular outcomes remains elusive. We aimed to investigate the effect of type 2 diabetes genetic risk–physical activity interaction on cardiovascular outcomes in individuals with diabetes. Methods and results: Using the UK Biobank cohort, we investigated the effect of type 2 diabetes genetic risk–physical activity interaction on three-point and four-point major adverse cardiovascular events (MACE), in 25 701 diabetic participants. We used a polygenic risk score for type 2 diabetes (PRS_T2D) as a measure of genetic risk for type 2 diabetes. We observed a significant interaction between PRS_T2D and physical activity on cardiovascular outcomes (three-point MACE: P trend for interaction = 0.0081; four-point MACE: P trend for interaction = 0.0037). Among participants whose PRS_T2D was in the first or second quartile, but not in the third or fourth quartile, each 10 metabolic equivalents (METs) hours per week of physical activity decreased the risk of three-point or four-point MACE. Furthermore, restricted cubic spline analysis indicated that intense physical activity (>80 METs hours per week, which was self-reported by 12.7% of participants) increased the risk of cardiovascular outcomes among participants whose PRS_T2D was in the fourth quartile. Sub-group analysis suggested that negative impact of intense physical activity was observed only in non-insulin users. Conclusion: The beneficial effect of physical activity on cardiovascular outcomes disappeared among those with high genetic risk for type 2 diabetes.
- 22 February 2024
- Published by Oxford University Press (OUP) in European Journal of Preventive Cardiology
- Vol. 31  (10) , 1277-1285
Open AccessInteraction between type 2 diabetes polygenic risk and physical activity on cardiovascular outcomes
Aims: The beneficial effects of exercise on reducing the risk of cardiovascular disease are established. However, the potential interaction between genetic risk for type 2 diabetes and physical activity on cardiovascular outcomes remains elusive. We aimed to investigate the effect of type 2 diabetes genetic risk–physical activity interaction on cardiovascular outcomes in individuals with diabetes. Methods and results: Using the UK Biobank cohort, we investigated the effect of type 2 diabetes genetic risk–physical activity interaction on three-point and four-point major adverse cardiovascular events (MACE), in 25 701 diabetic participants. We used a polygenic risk score for type 2 diabetes (PRS_T2D) as a measure of genetic risk for type 2 diabetes. We observed a significant interaction between PRS_T2D and physical activity on cardiovascular outcomes (three-point MACE: P trend for interaction = 0.0081; four-point MACE: P trend for interaction = 0.0037). Among participants whose PRS_T2D was in the first or second quartile, but not in the third or fourth quartile, each 10 metabolic equivalents (METs) hours per week of physical activity decreased the risk of three-point or four-point MACE. Furthermore, restricted cubic spline analysis indicated that intense physical activity (>80 METs hours per week, which was self-reported by 12.7% of participants) increased the risk of cardiovascular outcomes among participants whose PRS_T2D was in the fourth quartile. Sub-group analysis suggested that negative impact of intense physical activity was observed only in non-insulin users. Conclusion: The beneficial effect of physical activity on cardiovascular outcomes disappeared among those with high genetic risk for type 2 diabetes.
- Open Access
- 24 July 2023
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 120  (31)
NFIA in adipocytes reciprocally regulates mitochondrial and inflammatory gene program to improve glucose homeostasis
Adipose tissue is central to regulation of energy homeostasis. Adaptive thermogenesis, which relies on mitochondrial oxidative phosphorylation (Ox-Phos), dissipates energy to counteract obesity. On the other hand, chronic inflammation in adipose tissue is linked to type 2 diabetes and obesity. Here, we show that nuclear factor I-A (NFIA), a transcriptional regulator of brown and beige adipocytes, improves glucose homeostasis by upregulation of Ox-Phos and reciprocal downregulation of inflammation. Mice with transgenic expression of NFIA in adipocytes exhibited improved glucose tolerance and limited weight gain. NFIA up-regulates Ox-Phos and brown-fat-specific genes by enhancer activation that involves facilitated genomic binding of PPARγ. In contrast, NFIA in adipocytes, but not in macrophages, down-regulates proinflammatory cytokine genes to ameliorate adipose tissue inflammation. NFIA binds to regulatory region of the Ccl2 gene, which encodes proinflammatory cytokine MCP-1 (monocyte chemoattractant protein-1), to down-regulate its transcription. CCL2 expression was negatively correlated with NFIA expression in human adipose tissue. These results reveal the beneficial effect of NFIA on glucose and body weight homeostasis and also highlight previously unappreciated role of NFIA in suppressing adipose tissue inflammation.
- 24 July 2023
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 120  (31)
Open AccessNFIA in adipocytes reciprocally regulates mitochondrial and inflammatory gene program to improve glucose homeostasis
Adipose tissue is central to regulation of energy homeostasis. Adaptive thermogenesis, which relies on mitochondrial oxidative phosphorylation (Ox-Phos), dissipates energy to counteract obesity. On the other hand, chronic inflammation in adipose tissue is linked to type 2 diabetes and obesity. Here, we show that nuclear factor I-A (NFIA), a transcriptional regulator of brown and beige adipocytes, improves glucose homeostasis by upregulation of Ox-Phos and reciprocal downregulation of inflammation. Mice with transgenic expression of NFIA in adipocytes exhibited improved glucose tolerance and limited weight gain. NFIA up-regulates Ox-Phos and brown-fat-specific genes by enhancer activation that involves facilitated genomic binding of PPARγ. In contrast, NFIA in adipocytes, but not in macrophages, down-regulates proinflammatory cytokine genes to ameliorate adipose tissue inflammation. NFIA binds to regulatory region of the Ccl2 gene, which encodes proinflammatory cytokine MCP-1 (monocyte chemoattractant protein-1), to down-regulate its transcription. CCL2 expression was negatively correlated with NFIA expression in human adipose tissue. These results reveal the beneficial effect of NFIA on glucose and body weight homeostasis and also highlight previously unappreciated role of NFIA in suppressing adipose tissue inflammation.
- 19 May 2023
- Published by MyJove Corporation in Journal of Visualized Experiments
- No. 195,p. e65265
Semi-Automated Isolation of the Stromal Vascular Fraction from Murine White Adipose Tissue Using a Tissue Dissociator
The in vitro study of white, brown, and beige adipocyte differentiation enables the investigation of cell-autonomous functions of adipocytes and their mechanisms. Immortalized white preadipocyte cell lines are publicly available and widely used. However, the emergence of beige adipocytes in white adipose tissue in response to external cues is difficult to recapitulate to the full extent using publicly available white adipocyte cell lines. Isolation of the stromal vascular fraction (SVF) from murine adipose tissue is commonly executed to obtain primary preadipocytes and perform adipocyte differentiation. However, mincing and collagenase digestion of adipose tissue by hand can result in experimental variation and is prone to contamination. Here, we present a modified semi-automated protocol that utilizes a tissue dissociator for collagenase digestion to achieve easier isolation of the SVF, with the aim of reducing experimental variation, reducing contamination, and increasing reproducibility. The obtained preadipocytes and differentiated adipocytes can be used for functional and mechanistic analyses.
- 19 May 2023
- Published by MyJove Corporation in Journal of Visualized Experiments
- No. 195,p. e65265
Semi-Automated Isolation of the Stromal Vascular Fraction from Murine White Adipose Tissue Using a Tissue Dissociator
The in vitro study of white, brown, and beige adipocyte differentiation enables the investigation of cell-autonomous functions of adipocytes and their mechanisms. Immortalized white preadipocyte cell lines are publicly available and widely used. However, the emergence of beige adipocytes in white adipose tissue in response to external cues is difficult to recapitulate to the full extent using publicly available white adipocyte cell lines. Isolation of the stromal vascular fraction (SVF) from murine adipose tissue is commonly executed to obtain primary preadipocytes and perform adipocyte differentiation. However, mincing and collagenase digestion of adipose tissue by hand can result in experimental variation and is prone to contamination. Here, we present a modified semi-automated protocol that utilizes a tissue dissociator for collagenase digestion to achieve easier isolation of the SVF, with the aim of reducing experimental variation, reducing contamination, and increasing reproducibility. The obtained preadipocytes and differentiated adipocytes can be used for functional and mechanistic analyses.
- Open Access
- 7 February 2023
- Published by Elsevier in STAR Protocols
- Vol. 4  (1) , 102093
Chromatin immunoprecipitation with mouse adipocytes using hypotonic buffer to enrich nuclear fraction before fixation
- 7 February 2023
- Published by Elsevier in STAR Protocols
- Vol. 4  (1) , 102093
Open AccessChromatin immunoprecipitation with mouse adipocytes using hypotonic buffer to enrich nuclear fraction before fixation
- Top Cited PapersOpen Access
- 7 September 2022
- Published by Springer Nature in Nature Communications
- Vol. 13  (1) , 1-14
Beiging of perivascular adipose tissue regulates its inflammation and vascular remodeling
Although inflammation plays critical roles in the development of atherosclerosis, its regulatory mechanisms remain incompletely understood. Perivascular adipose tissue (PVAT) has been reported to undergo inflammatory changes in response to vascular injury. Here, we show that vascular injury induces the beiging (brown adipose tissue-like phenotype change) of PVAT, which fine-tunes inflammatory response and thus vascular remodeling as a protective mechanism. In a mouse model of endovascular injury, macrophages accumulate in PVAT, causing beiging phenotype change. Inhibition of PVAT beiging by genetically silencing PRDM16, a key regulator to beiging, exacerbates inflammation and vascular remodeling following injury. Conversely, activation of PVAT beiging attenuates inflammation and pathological vascular remodeling. Single-cell RNA sequencing reveals that beige adipocytes abundantly express neuregulin 4 (Nrg4) which critically regulate alternative macrophage activation. Importantly, significant beiging is observed in the diseased aortic PVAT in patients with acute aortic dissection. Taken together, vascular injury induces the beiging of adjacent PVAT with macrophage accumulation, where NRG4 secreted from the beige PVAT facilitates alternative activation of macrophages, leading to the resolution of vascular inflammation. Our study demonstrates the pivotal roles of PVAT in vascular inflammation and remodeling and will open a new avenue for treating atherosclerosis.
- 7 September 2022
- Published by Springer Nature in Nature Communications
- Vol. 13  (1) , 1-14
Top Cited PapersOpen AccessBeiging of perivascular adipose tissue regulates its inflammation and vascular remodeling
Although inflammation plays critical roles in the development of atherosclerosis, its regulatory mechanisms remain incompletely understood. Perivascular adipose tissue (PVAT) has been reported to undergo inflammatory changes in response to vascular injury. Here, we show that vascular injury induces the beiging (brown adipose tissue-like phenotype change) of PVAT, which fine-tunes inflammatory response and thus vascular remodeling as a protective mechanism. In a mouse model of endovascular injury, macrophages accumulate in PVAT, causing beiging phenotype change. Inhibition of PVAT beiging by genetically silencing PRDM16, a key regulator to beiging, exacerbates inflammation and vascular remodeling following injury. Conversely, activation of PVAT beiging attenuates inflammation and pathological vascular remodeling. Single-cell RNA sequencing reveals that beige adipocytes abundantly express neuregulin 4 (Nrg4) which critically regulate alternative macrophage activation. Importantly, significant beiging is observed in the diseased aortic PVAT in patients with acute aortic dissection. Taken together, vascular injury induces the beiging of adjacent PVAT with macrophage accumulation, where NRG4 secreted from the beige PVAT facilitates alternative activation of macrophages, leading to the resolution of vascular inflammation. Our study demonstrates the pivotal roles of PVAT in vascular inflammation and remodeling and will open a new avenue for treating atherosclerosis.
- Open Access
NFIA determines the cis-effect of genetic variation on Ucp1 expression in murine thermogenic adipocytes